Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1/Phase 2"
topic_facet:"Leukemia"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (337)
1
Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia : Humanized Chimeric Antigen Receptor T Cells Against CD7 for Refractory/Relapsed CD7+ Acute Leukemia
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL : A Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients With Large Granular Lymphocyte Leukemia or Refractory Cutaneous T-Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML) : Pilot Study of the Safety and Efficacy of Anti-CLL1 Chimeric Antigen Receptor Engineered T-Cells in the Treatment of CLL1 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy : Phase I/II Trial of MEK Inhibitor MEK162 in Patients With Relapsed and or Refractory Acute Myeloid Leukemia and Patients With Poor Prognosis Acute Myeloid Leukemia Not Suitable for or Unwilling to Receive Standard Therapy
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML : Phase I/II Study of Anti-CD19 Chimeric Antigen Receptor-Expressing T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia and Diffuse Large B Cell Lymphoma (DLBCL) or Primary Mediastinal B Cell Lymphoma (PML)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies : Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
ABT-751 With Chemotherapy for Relapsed Pediatric ALL : A Phase I/II Trial of ABT-751 Combined With Dexamethasone, PEG-asparaginase, and Doxorubicin in Relapsed Acute Lymphoblastic Leukemia (ALL)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients : Multicenter, Open-label, Phase Ib/II Trial to Evaluate Safety and Efficacy for the Combination of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Myeloid Leukemia Patients
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL : Clinical Trial for the Safety and Efficacy of Sequential CD19 and CD22 CAR-T Therapy for Adult Patients With Newly Diagnosed Ph Chromosome Positive B-cell Acute Lymphoblastic Leukemia
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL) : A Pilot Study on Intermittent and Repeated Dosing of Ibrutinib in the Treatment of Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[34]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1/Phase 2
Filter aufheben
Thema: Leukemia
Medienart
337
Aufsätze
337
E-Artikel
337
E-Ressourcen
Zeitschriftentitel
337
ClinicalTrials.gov
Thema
337
610
Leukemia
Phase: Phase 1/Phase 2
337
Study Type: Interventional
166
Recruitment Status: Completed
155
Leukemia, Myeloid
133
Leukemia, Myeloid, Acute
119
Leukemia, Lymphoid
97
Precursor Cell Lymphoblastic Leukemia-Lymphoma
78
Leukemia, Lymphocytic, Chronic, B-Cell
76
Myelodysplastic Syndromes
67
Lymphoma
61
Preleukemia
59
Recruitment Status: Terminated
53
Recruitment Status: Unknown status
45
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
38
Syndrome
34
Medical Condition: Acute Myeloid Leukemia
29
Recruitment Status: Recruiting
24
Lymphoma, Non-Hodgkin
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
78
2020-
251
2010-2019
8
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
337
Englisch
Haven't found what you're looking for?
Wird geladen...